台新藥 News Releases

Taihsin Pharmaceutical: Statement Regarding Investigation by Prosecutorial Authorities

Taihsin Pharmaceutical confirms it is fully cooperating with an investigation conducted by the Minis… · 2026-06-16

[PharmaEngine] Announcement of Exclusive Licensing Agreement for New Drug APP13007 for Post-Ophthalmic Surgery Inflammation and Pain Treatment in the Vietnamese Market with Samil Pharmaceutical

PharmaEngine (1587) announced the signing of an exclusive licensing agreement with Korea's Samil Pha… · 2026-06-11

[TSX] New Drug APP13007 Receives TFDA Approval

TSX announced that its new drug APP13007 (BYQLOVI) has been approved by the Ministry of Health and W… · 2026-06-01

[Formosa Pharmaceuticals] Resolution at the 115th Annual General Shareholders' Meeting to Lift Non-Compete Restrictions for Directors (including Independent Directors) (Correction of Fiscal Year)

At the annual shareholders' meeting on May 25, 115, Formosa Pharmaceuticals approved the lifting of … · 2026-05-25

【TaiRx】Resolution of the 2025 Annual General Meeting Regarding the Lifting of Non-Compete Restrictions for Directors (Including Independent Directors)

TaiRx held its annual general meeting on May 25, 2026, and approved the lifting of non-compete restr… · 2026-05-25

[TSX Therapeutics] Announcement of Key Resolutions from the 2026 Annual General Meeting

TSX Therapeutics held its annual general meeting on May 25, 2026, approving the 2025 financial state… · 2026-05-25

[Taiwan Medical] Announcement of Company's Consolidated Financial Report for Q1 115

Taiwan Medical announced its consolidated financial report for the first quarter of 2026. The compan… · 2026-05-11

[Taiwan Medical] Announcement of Company's Consolidated Financial Report for Q1 115

Taiwan Medical announced its consolidated financial report for the first quarter of 2026. The compan… · 2026-05-11

【TLC】Announcement of the Board of Directors Meeting Date for the Company's 2026 First Quarter Financial Report

TLC announced that its Board of Directors meeting for the 115th fiscal year (2026) first quarter fin… · 2026-05-06

【TLC】Announcement of the Board of Directors Meeting Date for the Company's 2026 First Quarter Financial Report

TLC announced that its Board of Directors meeting for the 115th fiscal year (2026) first quarter fin… · 2026-05-06

[Formosa Pharmaceuticals] May 2026 Revenue Reaches NT$ 2.35 Million (Down 50.7% YoY)

Biotech company Formosa Pharmaceuticals (6838) announced its May 2026 revenue of NT$ 2.35 million, r… · 2026-05-01

Tashin Pharmaceutical Reports Zero Revenue for April 2026

Tashin Pharmaceutical reported zero revenue for April 2026. The company, operating in the biotechnol… · 2026-04-01

Tashin Pharmaceutical Reports Zero Revenue for April 2026

Tashin Pharmaceutical reported zero revenue for April 2026. The company, operating in the biotechnol… · 2026-04-01

Tai Shin Pharmaceutical: March 2026 Monthly Revenue 0.044 Billion (Y-o-Y Not Provided)

Tai Shin Pharmaceutical, a company in the biotechnology and medical industry, announced its monthly … · 2026-03-01

Tai Shin Pharmaceutical: March 2026 Monthly Revenue 0.044 Billion (Y-o-Y Not Provided)

Tai Shin Pharmaceutical, a company in the biotechnology and medical industry, announced its monthly … · 2026-03-01

[TLC] February 2026 Revenue: 0.01 Billion (+120.2% YoY)

TLC (6838) announced its financial report for February 2026. The company's revenue for the month was… · 2026-02-01

[TLC] February 2026 Revenue: 0.01 Billion (+120.2% YoY)

TLC (6838) announced its financial report for February 2026. The company's revenue for the month was… · 2026-02-01